Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets by Gururajan, Murali et al.
Toll-Like Receptor Expression and Responsiveness of
Distinct Murine Splenic and Mucosal B-Cell Subsets
Murali Gururajan
1, Joshy Jacob
1,3, Bali Pulendran
1,2*
1Vaccine Research Center, Emory University, Atlanta, Georgia, United States of America, 2Departments of Pathology, Emory University, Atlanta,
Georgia, United States of America, 3Microbiology and Immunology, Emory University, Atlanta, Georgia, United States of America
Background. Toll-like receptors (TLRs) are pattern recognition receptors that recognize pathogen associated molecular
patterns and trigger innate immunity leading to initiation of adaptive immunity. TLR-mediated activation of dendritic cells
(DCs) is known to be a critical event in the initiation of cellular and humoral immune responses. Recent work however suggests
that B cells also express TLRs, and that they can be activated via TLR ligands. However, whether such B cell activation occurs
only on memory B cells, or whether it can also occur on truly naı ¨ve B cells remains controversial. Furthermore, the expression
and functional relevance of TLRs on distinct subsets of B cells, which are known to play differential roles in humoral responses
is not known. Methodology/Principal Findings. In this study, we investigated the expression pattern of different TLRs in
distinct subsets of murine B cells (naı ¨ve, memory, follicular, marginal zone, B-1 and peyer’s patch). In contrast to the reported
restricted expression pattern of TLRs in human peripheral blood naı ¨ve B cells, murine splenic naı ¨ve B cells express a variety of
TLRs with the exception of TLR5 and 8. Consistent with this relatively broad expression pattern, murine naive B cells proliferate
and secrete antibody to a variety of TLR agonists in vitro, in the absence of B-cell receptor cross-linking. In addition, we
observed subtle differences in the antibody secretion pattern of follicular, marginal zone, B-1 and peyer’s patch B-cell subsets.
Conclusions/Significance. Thus various B cell subsets, including truly naı ¨ve B cells, express multiple TLRs, and signaling via
such TLRs results in their robust proliferation and antibody secretion, even in the absence of dendritic cell activation, or T-cell
help.
Citation: Gururajan M, Jacob J, Pulendran B (2007) Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell
Subsets. PLoS ONE 2(9): e863. doi:10.1371/journal.pone.0000863
INTRODUCTION
TLR-mediated recognition of microbial stimuli often leads to
activation of innate immune cells including dendritic cells (DCs)
[1,2,3]. TLR signaling promotes activation and maturation of DCs
which instruct and support T-cell activation, leading to cell-
mediated adaptive immune response [4]. Cognate interaction
between activated antigen-specific T cells and naı ¨ve B cells
promotes B-cell clonal expansion and differentiation leading to
a humoral immune response. Differential expression pattern of
TLRs have been reported in human and murine DC subsets [5,6].
In humans, myeloid DCs express TLR2 and 4, whereas
plasmacytoid DCs express TLR7 and 9 [7].
Recent studies suggests that in addition to TLR signaling in
DCs, direct TLR mediated activation of B cells is also required for
eliciting humoral immune response [8]. Thus chimeric mice in
which only B cells are deficient in TLR signaling, fail to mount
antibody responses to protein antigens given with adjuvants [8].
Consistent with this observation, previous work suggests that
murine B cells can be stimulated in vitro by TLR4 and TLR9
ligands to proliferate and secrete antibody [9,10]. ln contrast to
murine B cells, naı ¨ve human B cells do not express TLR4 or
TLR9 and hence do not respond directly to LPS or CpG [11].
However, it was recently reported that human memory B cells in
the blood do express TLR9 and respond to CpG DNA [12], and
consistent with this, cross-linking of BCR results in upregulation of
TLR9 expression, and responsiveness to TLR9 ligands [12]. In
contrast to this, recent studies revealed no differences in TLR
expression in naı ¨ve versus germinal center versus memory B cells
in human tonsils [13,14].
Therefore, TLR activation of B cells likely plays a critical role in
the regulation of humoral immunity and memory, and un-
derstanding the precise roles played by different TLRs in this
regard is a critical first step in exploiting this in the design of
vaccines that induce rapid and persistent neutralizing antibody.
However, this is complicated by the fact that there are several
subsets of B cells that play distinct roles during immune responses.
For example, follicular B cells are shown to be important for T-
dependent immune responses whereas marginal zone B cells are
important for T-independent immune responses [15]. Marginal
zone B cells are shown to be in a pre-activated state and respond
rapidly to LPS and secrete antibody in vitro [16]. Peyer’s patch B
cells in the intestine play critical role in mucosal immune response
by secreting IgA that binds to pathogens and prevents enteric
infections [17]. B-1 B cells, a subset of B cells in the peritoneal
cavity is the source of natural IgM present in the serum and plays
an important role in immunity against blood borne pathogens
[18]. However, the expression patterns of TLRs on distinct B-cell
subsets, and their responsiveness to various TLR ligands is poorly
understood.
To understand the importance of TLR signaling in B cells and
to clarify the differences reported to exist between mouse and
human B cells, we determined the expression pattern of TLRs in
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in vitro in the absence of antigenic stimulation (BCR cross-linking).
Our data suggest that mouse naı ¨ve follicular B cells express and
undergo polyclonal expansion and differentiation to almost all
known TLRs except TLR5 and 8. We demonstrate that different
B-cell subsets including follicular, marginal zone, B-1 and peyers
patch B cells proliferate and secrete polyclonal antibodies to
a variety of TLR agonists in vitro.
MATERIALS AND METHODS
Mice
C57BL/6 mice were purchased from Jackson Laboratory (Maine).
ROSAYFP [19] and germinal center-cre (GCC) [19] mice were
genotyped via PCR of genomic DNA derived from tail-tip
biopsies. Primers for ROSAYFP PCR and Cre-PCR have been
described [19] . All GCC mice were maintained by mating with
C57BL/6 and housed under specific pathogen-free conditions at
the Emory Vaccine Center. All animal studies were approved by
the Institutional Animal Care and Use Committee of Emory
University.
Flow cytometry
Splenic B cells were bead purified using CD19 microbeads
(Miltenyi Biotech). CD19 enriched B cells were stained for
Cychrome anti-CD45R/B220 (RA3-6B2), PE anti-CD23 and
FITC anti-CD21 (BD Pharmingen, San Jose, CA). B-cell subsets
were FACS sorted using a MoFlo cell sorter (DakoCytomation,
Fort Collins, CO).
Real-time PCR
Total RNA was isolated from FACS sorted B cell subsets with the
RNA miniprep (Invitrogen, Carlsbad, CA). RNA was quantified
by OD260 using a DUH 530 Life Science UV Spectrophotometer
(Beckman Coulter Inc, CA) and 2 mg of total RNA was
subsequently used to make cDNA using the Superscript II reverse
transcriptase (Invitrogen Corp., Carlsbad, CA) according to the
manufacturer’s protocol. RT-PCR was performed using Biorad
apparatus (Biorad Laboratories, Hercules, CA). Primers for
murine TLRs were used as reported previously [5]. The b-actin
specific primers were used for loading control (IDT technologies,
Corallevielle, IA).
Proliferation Assay
FACS sorted B-cell subsets were incubated at 2610
5 cells/well
in triplicate in 96-well flat-bottom plates in medium consisting
of RBMI-1640 supplemented with 10 mM glutamine, 10 mM
HEPES, 0.5 mg/ml gentamicin, and 5610
25 2-ME (Complete
IF-12 media). Stimuli added included (Fab’)2 goat anti-IgM
(m-chain specific; ICN Pharmaceuticals, Cappel, ICN Pharma-
ceuticals, Aurora, OH)) LPS (Invivogen), CpG ODN 1826
(Coley Pharmaceuticals, Wellesley, MA), Pam3Cys (EMC
microcollections, Germany), MALP-2 (Invivogen, San Diego,
CA), and 3M-003 (kind gift from Dr. Sefik Alkan, 3M
pharmaceuticals, St. Paul, MN). After 66 h, all cultures were
pulsed with 1 mCi of [
3H]thymidine and harvested 6 h later onto
filter mats using a cell harvester (Packard, Meriden, CT). The
levels of radionucleotide incorporation were measured with
a Matrix 96 ß-radiation counter (Packard, Downers Grove, IL).
Results were presented as arithmetic mean of triplicate cultures
6SE.
ELISA
FACS sorted B-cell subsets were incubated at 2610
5 cells/well in
triplicate cultures in 96-well flat-bottom plates for 5 days. Day 5
Figure 1. TLR expression profile of murine B-cell subsets. Real-time PCR profile of TLR expression in FACS sorted follicular B-cells (CD19
+
B220
+CD23
+CD21
2, panel A), marginal Zone B (CD19
+ B220
+CD23
2CD21
+, panel B), peritoneal B-1 (CD19
+B220
+CD23
2, panel C) and peyer’s patch B
cells (CD19
+B220
+, panel D) as indicated with b-actin as loading control. CD11c+ dendritic cells were used as a positive control (panel E). Values
represent the ratio of the TLR to b-actin.
doi:10.1371/journal.pone.0000863.g001
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(BD Biosciences, San Jose, CA).
Immunization
C57BL/6 mice were immunized with sheep RBC (SRBC) 10% v/
v intraperitoneally. On day 12, mice were sacrificed and B220
+
PNA
2 IgG
+ splenic memory B cells FACS sorted using a MoFlo
cell sorter (DakoCytomation, Fort Collins, CO) as described
previously [20].
RESULTS AND DISCUSSION
Expression profiles of TLRs in different B-cell subsets
We determined the expression pattern of TLRs1-9 in the following
murine B-cell subsets i) splenic follicular ii) splenic marginal zone,
iii) peritoneal B-1 and iv) mucosal peyer’s patch B cells. In initial
experiments, splenic follicular, marginal zone, peritoneal B-1 and
peyer’s patch B-cells were screened for expression of 9 known
TLRs. Total B cells were isolated from murine spleen using CD19
microbeads and stained with antibodies to B220, CD23 and CD21
to distinguish different subsets. Splenic follicular (B220
+CD23
+
CD21
2) and marginal zone (B220
+CD23
2CD21
+) B cells were
sorted by cell sorting. The expression of different TLRs was
assessed by real-time PCR with b-actin as loading control. All B-
cell subsets expressed TLRs 1, 2, 3, 4, 6, 7 and 9 to varying
degrees but not TLRs 5 and 8 (Figures 1A–D). As a positive
control, CD11c
+ murine splenic DCs were used. CD11c
+ DCs
express all known TLRs (Figure 1E). B-1 B cells (B220
+CD19
+
CD23
2), a subset of B cells important for T-independent immune
response present in the peritoneal cavity expressed a similar TLR
pattern like splenic B cells except TLRs 1/2 and 6 (Figures 1C).
Follicular, marginal zone, B-1 and peyer’s patch B
cells proliferate and secrete polyclonal antibodies to
various TLR agonists
First, we studied the functional relevance of TLR expression by
various B-cell subsets. We found that murine B-cell subsets
proliferate in response to 1 mg/ml of Pam3Cys (TLR2 agonist),
LPS (TLR4 agonist), TLR2/6 (MALP-2), 3M-003 (TLR7/8
agonist) and CpG (TLR9 agonist) (Figures 2A-D) with varying
degrees. Follicular B cells proliferate robustly in response to most
of the TLR agonists except for TLR3 and TLR6, where the
response is weak or absent and for TLR5 where the response is
absent. Interestingly, marginal zone B cells proliferate robustly in
response to TLR2 (Pam3Cys) and TLR6 (MALP-2) agonists but
weakly to TLR4, 7 and 9 agonists. B-1 B cells respond weakly to
most of the TLR agonists except TLRs 4, 7 and 9. Robust
proliferation of peyer’s patch B cells was observed in response to
TLR2, 6 and 7 ligation but not other TLRs. Alternately, CFSE
Figure 2. TLR-induced proliferation of murine B-cell subsets. A, FACS sorted follicular B-cells (CD19
+ B220
+CD23
+CD21
2) were cultured in vitro with
various TLR ligands as indicated for 3 days and proliferation measured as described in Materials and Methods. B-D, FACS sorted marginal zone, B-1,
and peyer’s patch B-cells (CD19
+ B220
+CD23
2CD21
+ for marginal zone B, CD19
+B220
+CD23
2 for peritoneal B-1 B and CD19
+B220
+ for peyer’s patch B
cells) were cultured in vitro with various TLR ligands as indicated for 3 days and proliferation measured by thymidine incorporation as described in
Materials and Methods.
doi:10.1371/journal.pone.0000863.g002
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measured and B-cells appear to undergo multiple cell divisions in
vitro (data not shown). The dose we used to stimulate B cells is
optimal since dendritic cells stimulated with 1 mg/ml of TLR
ligands secrete cytokines like IL-6, IL-12p40 and IL-10 depending
on the stimulus [21,22]. Follicular and marginal zone B cells not
only clonally expand in response to TLR ligation but also secrete
antibodies of all isotypes except IgA which was abundantly secreted
by B-1 and peyer’s patch B cells (Figures 3A-D). Consistent with
their pre-activated phenotype, B-1 B cells have higher background
IgM response and Peyer’s patch B cells have higher IgA response in
unstimulated conditions (Figure 3C & D) [18,23]. The isotype
profile appears to be different depending on the subset studied and
the ligand used. Thus, our studies demonstrate that not only do
different B-cell subsets express TLRs, but that they can also be
stimulated directly by TLR ligands.
Both naı ¨ve and memory murine B cells respond to
TLR agonists in vitro in the absence of BCR cross-
linking
In humans, memory but not naı ¨ve B cells express and respond to
TLR9 ligands in the absence of BCR triggering [12,24]. However,
in mice previous studies suggest that so-called naı ¨ve splenic B cells
do respond directly to TLR stimulation [9,10]. In our preliminary
experiments, we sorted B220
+CD23
+CD21
2 IgG
2, putative naı ¨ve
B cells and stimulated them in vitro with TLR ligands and
observed proliferation and antibody secretion (data not shown).
However it was formally possible that putative IgM
+ memory B
cells might have been present in the B220
+CD23
+CD21
2 IgG
2
fraction. To definitively address the issue of whether bona fide
naı ¨ve B cells express TLRs and are responsive to TLR ligands, we
utilized the recently described transgenic mouse system where
memory B cells are marked based on YFP expression and can be
tracked in vivo [19]. This transgenic system utilized the I-Ea
d
promoter and gene expression from this promoter was restricted in
B lineage cells that had entered the germinal center (GC) pathway
of B cell differentiation. The transgenic mice were subsequently
bred to the ROSAYFP cre-reporter strain, in which constitutive
expression of YFP occurs upon cre-mediated recombination of the
ROSAlocus [19]. We FACS sorted naı ¨ve follicular (B220
+ CD23
+
YFP
2 IgM
+) B cells from these transgenic mice thereby effectively
excluding the contaminating memory B-cell population
(Figure 4A). In parallel, we FACS sorted memory (B220
+
CD23
+ IgG
+) B cells from sheep RBC (SRBC) immunized mice,
and studied the expression and functional role for TLRs.
Figure 3. TLR-induced B-cell differentiation and immunoglobulin secretion of murine B-cell subsets. A, FACS sorted follicular B-cells (CD19
+
B220
+CD23
+CD21
2) were cultured in vitro with various TLR ligands as indicated for 5 days and antibody profile of culture supernatants measured by
ELISA as described in Materials and Methods. B-D, FACS sorted marginal zone, B-1 and peyer’s patch B-cells (CD19
+ B220
+CD23
2CD21
+ for marginal
zone B, CD19
+B220
+CD23
2for peritoneal B-1 B and CD19
+B220
+ for peyer’s patch B cells) were cultured in vitro with various TLR ligands as indicated
for 5 days and antibody secretion measured by ELISA as described in Materials and Methods.
doi:10.1371/journal.pone.0000863.g003
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cells was almost identical (Figure 4B). Unlike human peripheral
blood naı ¨ve B cells, murine splenic naı ¨ve B cells respond to TLR
ligation (proliferation and antibody secretion) equally well
compared to unsorted B cells, ruling out potential memory B cell
contamination in the subsets studied (Figure 4C & D).
In summary, we report here the expression pattern and function
of TLRs in different murine B-cell subsets including follicular,
marginal zone, B-1 and Peyer’s patch. B-cell subsets express all
known TLRs except 5 and 8. Consistent with their expression
pattern, FACS sorted purified B-cell subsets respond to TLR
ligands in vitro (Figure 5). Robust proliferation and antibody
secretion of follicular B cells was observed in response to various
TLR ligands, particularly ligands to TLR2/1, TLR2/6, TLRs 4, 7
and 9 (Figure 5). Marginal zone B cells have a similar pattern of
TLR expression and response (Figure 5). However, B-1B cells do
not respond strongly to TLR2 ligands. In contrast, Peyer’s patch B
cells respond robustly to TLR2, 6 and 7 ligation, but poorly to
ligands for TLR9 and 4. Our results are consistent with a very
recent report that B-cell subsets that participate in T-independent
immune response express and respond to TLR agonists in vitro
[25]. But in contrast to their observations, we show that follicular
B cells that participate in T-dependent immune response do
express and secrete antibodies of IgG3 and IgM isotypes in
response to a variety of TLR agonists in vitro [25]. The observed
differences between our study and the previous study could be due
to different CpG motifs that were used (CpG 1826 versus CpG
1668). It is possible that the CpG ODN we used (CpG 1826) was
more potent than the one used in the previous study (CpG 1668)
[25,26].
Furthermore, we addressed the issue of TLR expression and
function in naı ¨ve versus memory B cells and found that mouse
Figure 4. TLR induced proliferation and immunoglobulin secretion of naı ¨ve follicular B cells. A, Splenocytes taken from naive GCCxRosaYFP mice
were stained with anti-B220-allophycocyanin and anti-CD23-phycoerythrin to detect follicular B cells. B220
+ CD23
+ cells were further gated for YFP
and IgM expression. Numbers shown in each plot indicate frequency of gated cells within total lymphocytes. FACS profile of Naı ¨ve (B220
+ CD23
+
eYFP
2 IgM
+) B cells pre-sort and post-sort. The purity of post-sort was ,99%. B, FACS sorted naı ¨ve B cells as described in panel A and memory B cells
(B220
+ CD23
+ IgG
+) from 10% v/v SRBC immunized mice (day 12) were probed for TLR expression by Real-time PCR, C, FACS sorted naı ¨ve B cells were
cultured in vitro in the presence of various TLR ligands for 3 days and proliferation measured by thymidine incorporation as described in Materials
and Methods. D, FACS sorted naı ¨ve B cells were cultured in vitro in the presence of TLR ligands for 5 days, culture supernatants were harvested and
ELISA was performed as described in Materials and Methods. Experiments were performed three times with similar results and a representative profile
is shown.
doi:10.1371/journal.pone.0000863.g004
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a variety of TLR agonists in vitro. The extent to which TLR
signaling in B cells modulate antibody responses to vaccines needs
to be examined. Surprisingly, a recent report from Gavin et al
demonstrated that certain commonly used adjuvants including
CFA and Ribi do not require TLRs for eliciting antibody
responses [27]. In contrast, it was shown that VSV induced IgM
neutralizing antibody was partially dependent on TLR7 [28].
Furthermore, our recent study suggests that the yellow fever
vaccine-17D, one of the most effective vaccines stimulates T cell
responses by activating multiple TLRs [29], although to what
extent TLR signaling influences humoral immune responses need
to be determined.
In conclusion, the data presented here highlight the importance
of TLR expression and function in different murine B-cell subsets
which contribute to T-dependent and T-independent responses
and signifies the potential fundamental differences that exist
between human and mouse naı ¨ve B cells.
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Figure 5. A heat map summary of TLR expression and responsiveness to different TLR ligands by distinct murine B cell subsets. The values for
TLR expression profile, proliferation and antibody secretion in response to various TLR ligands by different B-cell subsets shown in Figures 1–3 were
plotted on a log scale, and represented as a heat map. For TLR expression, blue represents an 1 fold increase relative to b-actin, green represents 2
fold increase, yellow represents 3 fold increase, red represents 4 fold increase and dark brown represents $5 fold increase. For proliferation, blue
represents an 1 fold increase relative to unstimulated medium controls, green represents 2 fold increase, yellow represents 3 fold increase, red
represents 4 fold increase and dark brown represents 5 fold increase. For antibody secretion, blue represents an 1 fold increase relative to
unstimulated medium controls, green represents 2 fold increase, yellow represents 3 fold increase, red represents 4 fold increase and dark brown
represents 5 fold increase.
doi:10.1371/journal.pone.0000863.g005
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